Recombinant Human CHDH Protein: Handling & Application Protocol

Recombinant Human CHDH Protein is a mitochondria-associated flavoenzyme that catalyzes the oxidation of choline to betaine aldehyde, making it an essential tool for studying choline metabolism, osmotic stress responses, and mitochondrial function in human disease models.

Product Name

Recombinant Human CHDH Protein

SKU

rp369972

Protein Function

Catalyzes oxidation of choline to betaine aldehyde (choline dehydrogenase activity)

Subcellular Localization

Mitochondrial inner membrane

Host Expression System

Refer to product datasheet for confirmed expression system

Recommended Storage

-80°C for long-term storage; avoid repeated freeze-thaw cycles

Application Areas

Enzyme activity assays, western blot, ELISA, functional biochemical studies

Overview of CHDH and Biological Significance

Choline Dehydrogenase (CHDH) is a mitochondria-localized flavoprotein oxidoreductase encoded by the CHDH gene in humans. It catalyzes the first step in the betaine biosynthesis pathway: the NAD⁺-dependent oxidation of choline to betaine aldehyde. Betaine, the downstream metabolite, serves as an important osmolyte and methyl-group donor in one-carbon metabolism.

CHDH activity is critical for maintaining mitochondrial integrity, spermatogenesis, and cellular osmotic balance. Dysregulation of CHDH has been associated with male infertility, metabolic disorders, and impaired mitochondrial function. Recombinant Human CHDH Protein (rp369972) enables researchers to study these pathways under controlled in vitro conditions, facilitating enzyme kinetics studies, inhibitor screening, and mechanistic investigations.

Reconstitution and Storage Protocol

Materials Required:

• Recombinant Human CHDH Protein (rp369972)
• Sterile deionized water or manufacturer-recommended reconstitution buffer (refer to product datasheet)
• Low-protein-binding microcentrifuge tubes
• Carrier protein (e.g., 0.1% BSA) for dilution, if required

Reconstitution Steps:

1. Briefly centrifuge the vial at low speed (≤1,000 × g, 30 seconds) to collect lyophilized material at the bottom before opening.
2. Add the recommended volume of sterile reconstitution buffer as specified on the product datasheet. Do not vortex; gently pipette to mix.
3. Allow the protein to dissolve at room temperature for 10–15 minutes, then gently swirl.
4. Aliquot the reconstituted protein into single-use volumes to avoid repeated freeze-thaw cycles.

Storage Conditions:

• Short-term (≤1 week): Store at 4°C.
• Long-term: Store at -80°C. Avoid repeated freeze-thaw cycles, as this may reduce enzymatic activity and protein integrity.
• Addition of a carrier protein (0.1% BSA) is recommended for dilute working solutions to minimize adsorption losses.

Note: Always consult the product-specific datasheet supplied with rp369972 for exact buffer composition, reconstitution volume, and concentration.

Application Protocol: Choline Dehydrogenase Enzyme Activity Assay

The following general protocol outlines how to assess CHDH enzymatic activity in a spectrophotometric or fluorometric format. Exact assay conditions should be optimized empirically based on the specific assay kit or reagent set used in your laboratory.

Principle: CHDH catalyzes the oxidation of choline coupled to the reduction of NAD⁺ to NADH. NADH production can be monitored at 340 nm (absorbance) or via a fluorescent readout when coupled to an appropriate detection reagent.

Recommended Assay Setup:

1. Prepare assay buffer: Use 50 mM potassium phosphate buffer, pH 8.0 (or as specified in your assay kit). Equilibrate to assay temperature (typically 25–37°C).
2. Prepare substrate solution: Dissolve choline chloride in assay buffer to the desired concentration (e.g., 1–10 mM). Prepare fresh.
3. Prepare enzyme solution: Dilute rp369972 to the appropriate working concentration in assay buffer containing 0.1% BSA. Confirm working concentration from the product datasheet.
4. Assemble reaction: In a 96-well microplate or cuvette, combine assay buffer, NAD⁺ (1 mM final), substrate (choline chloride), and initiate by adding the enzyme solution. Total reaction volume: 100–200 µL.
5. Monitor reaction: Record absorbance at 340 nm at 30-second intervals for 10–30 minutes at the selected assay temperature.
6. Calculate activity: Use the molar extinction coefficient of NADH (6,220 M^-1cm^-1 at 340 nm) to calculate enzyme-specific activity.

Important: All assay conditions, including enzyme and substrate concentrations, should be validated with appropriate positive and negative controls.

Quality Control and Troubleshooting

Quality Control Checks:

• Purity assessment: Verify protein purity by SDS-PAGE. A single predominant band at the expected molecular weight of CHDH should be observed. Refer to the product datasheet for confirmed purity specification.
• Protein concentration: Measure absorbance at 280 nm (A280) using a NanoDrop or similar instrument and calculate concentration using the predicted extinction coefficient, or use a BCA/Bradford assay.
• Activity confirmation: Include a positive control (e.g., a well-characterized CHDH preparation) and a no-enzyme blank in every assay.

Common Issues and Solutions:

Issue	Possible Cause	Recommended Action
Low or no enzyme activity	Freeze-thaw damage or improper reconstitution	Use freshly reconstituted protein; avoid multiple freeze-thaw cycles
High background signal	Contaminating oxidase activity or reagent impurity	Include no-enzyme blank; use fresh reagents
Protein aggregation	Excess freeze-thaw or incorrect buffer	Centrifuge briefly before use (10,000 × g, 5 min, 4°C); use recommended buffer
Inconsistent results	Pipetting error or temperature variation	Pre-warm assay components; calibrate pipettes; use thermostated plate reader

Safety, Disposal, and Regulatory Notes

Safety Handling:

• Handle Recombinant Human CHDH Protein using standard laboratory safety practices (lab coat, gloves, eye protection).
• Although this recombinant protein is not classified as a biohazard under standard research use conditions, treat all biological materials with appropriate care.
• Avoid inhalation or ingestion of lyophilized protein powders.

Disposal:

• Dispose of protein solutions and contaminated materials in accordance with your institution's biosafety guidelines and local regulations for biological waste.
• Inactivate protein solutions before disposal if required by institutional policy (e.g., autoclaving or chemical inactivation).

Regulatory:

• This product is for research use only (RUO). It is not approved for diagnostic, therapeutic, or clinical use.
• Consult your institution's biosafety committee for site-specific requirements.

Frequently asked questions

What is the recommended reconstitution buffer for Recombinant Human CHDH Protein (rp369972)?

The reconstitution buffer and volume are specified on the product datasheet supplied with rp369972. Generally, sterile deionized water or a phosphate-based buffer supplemented with a carrier protein such as 0.1% BSA is suitable for many recombinant proteins to maintain stability. Always follow the lot-specific datasheet for confirmed recommendations.

How should I store Recombinant Human CHDH Protein to preserve its activity?

For long-term storage, aliquot the reconstituted protein and store at -80°C. For short-term use within one week, storage at 4°C is acceptable. Repeated freeze-thaw cycles should be avoided, as they can significantly reduce enzymatic activity and protein integrity. Adding 0.1% BSA to dilute solutions helps minimize adsorption to tube surfaces.

What applications is Recombinant Human CHDH Protein suitable for?

Recombinant Human CHDH Protein (rp369972) is suitable for enzyme activity assays (e.g., monitoring NAD+-to-NADH conversion), western blot analysis, ELISA, inhibitor screening, and mechanistic studies of choline metabolism and mitochondrial function. Consult the product datasheet for validated applications specific to this lot.

Can Recombinant Human CHDH Protein be used in clinical or diagnostic applications?

No. Recombinant Human CHDH Protein (rp369972) is strictly for research use only (RUO) and is not approved or validated for diagnostic, therapeutic, or clinical applications. Use in such contexts would require separate regulatory review and validation.

How do I verify the quality of the Recombinant Human CHDH Protein upon receipt?

Upon receipt, inspect the vial for integrity and verify the lot-specific certificate of analysis (CoA). After reconstitution, run SDS-PAGE to confirm a predominant band at the expected molecular weight for CHDH, and measure protein concentration by A280 or a colorimetric assay. Include an enzyme activity assay with a positive control to confirm biological activity.

References

1. Huang S, et al. Choline dehydrogenase (CHDH) and its role in mitochondrial function and male fertility — a review of current literature. (General reference; verify specific publication details.)
2. Ueland PM. Choline and betaine in health and disease. Journal of Inherited Metabolic Disease. (General reference; exact volume, issue, and page numbers require verification.)
3. Enzyme nomenclature: Choline dehydrogenase (EC 1.1.99.1). ExplorEnz — The Enzyme Database. Available at: https://www.enzyme-database.org/

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.